findmyKOL
Clinical trialNCT02941549CompletedPhase 2Interventional

Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD

SponsorAfimmuneEnrollment96Non Alcoholic Fatty Liver Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Georgia
  • Georgia Site 1

    Kutaisi, Georgia

  • Georgia Site 2

    Kutaisi, Georgia

  • Georgia Site 3

    Tbilisi, Georgia

Ukraine
  • Ukraine Site 3

    Dnipro, Ukraine

  • Ukraine Site 1

    Kharkiv, Ukraine

  • Ukraine Site 2

    Kyiv, Ukraine

  • Ukraine Site 4

    Kyiv, Ukraine

United Kingdom
  • Uk Site 1

    Birmingham, UK, United Kingdom

  • Uk Site 5

    Birmingham, UK, United Kingdom

  • Uk Site 6

    London, UK, United Kingdom

  • Uk Site 7

    Norwich, UK, United Kingdom

  • Uk Site 3

    Oxford, UK, United Kingdom

  • Uk Site 4

    Plymouth, UK, United Kingdom

  • Uk Site 2

    Portsmouth, UK, United Kingdom

  • Uk Site 9

    Belfast, United Kingdom

  • Uk Site 8

    Liverpool, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Dec 2016
Primary completion
2 Jan 2019
Completion
4 Mar 2019
Last update posted
12 Oct 2022
Registered enrollment
96
Registry id
NCT02941549

Cross-registrations

EU-CTR / CTIS (EudraCT)2016-000311-33

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.